# OnCo record paper-nct05081609-j-immunother-cancer-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct05081609-j-immunother-cancer-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct05081609-j-immunother-cancer-2022" ;
  schema:name "TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancer"@en ;
  schema:description "Published report from the trial registered as NCT05081609, in Journal for ImmunoTherapy of Cancer (2022), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct05081609-j-immunother-cancer-2022/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1136/jitc-2022-004991>, <https://pubmed.ncbi.nlm.nih.gov/35817480/>, <https://europepmc.org/article/MED/35817480>, <https://clinicaltrials.gov/study/NCT05081609> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1136/jitc-2022-004991> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Rosen DB, Kvarnhammar AM, Laufer B, et al." ;
  onco:trials <https://onco.cc/trials/nct05081609/> ;
  onco:journals <https://onco.cc/journals/jitc/> .